We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEL
251
DELISTED
American Equity Investment Life Holding Company
AEL
| $8.12M | 0.08% |
369,278
-23,573
| -6% | -$563K |
|
252
Benchmark Electronics
BHE
$2.66B
| $8.11M | 0.08% |
402,536
-78,311
| -16% | -$1.59M |
|
253
Frontdoor
FTDR
$5.27B
| $8.11M | 0.08% |
208,453
+2,139
| +1% | +$91.3K |
|
254
Gossamer Bio
GOSS
$101M
| $8.02M | 0.08% |
646,413
+383,635
| +146% | +$5.09M |
|
|
KYNB
255
Kyntra Bio
KYNB
$27.4M
| $7.94M | 0.08% |
+7,725
| New | +$8.31M |
|
256
Primoris Services
PRIM
$4.06B
| $7.91M | 0.08% |
438,335
-27,193
| -6% | -$481K |
|
257
NVR
NVR
$17.1B
| $7.71M | 0.08% |
1,889
-676
| -26% | -$2.61M |
|
|
RESI
258
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $7.71M | 0.08% |
881,819
-123,703
| -12% | -$1.12M |
|
259
Liberty Global Class A
LBTYA
$3.59B
| $7.7M | 0.08% |
366,679
+16,775
| +5% | +$377K |
|
260
Acuity Brands
AYI
$9.99B
| $7.67M | 0.08% |
74,956
-96
| -0.1% | -$9.86K |
|
261
Apogee Enterprises
APOG
$833M
| $7.66M | 0.08% |
358,567
-140,312
| -28% | -$3.07M |
|
262
Bally's
BALY
$708M
| $7.55M | 0.08% |
287,487
+316
| +0.1% | +$7.34K |
|
263
XPO
XPO
$23.4B
| $7.53M | 0.08% |
257,013
-177,245
| -41% | -$5.1M |
|
|
TRUE
264
DELISTED
TrueCar
TRUE
| $7.48M | 0.08% |
1,495,508
-39,204
| -3% | -$165K |
|
265
Conduent
CNDT
$253M
| $7.47M | 0.08% |
2,350,627
-566,967
| -19% | -$1.68M |
|
266
UMB Financial
UMBF
$11.3B
| $7.4M | 0.08% |
151,030
-10,441
| -6% | -$527K |
|
267
Employers Holdings
EIG
$907M
| $7.39M | 0.08% |
244,437
-5,570
| -2% | -$176K |
|
268
Camden Property Trust
CPT
$11.5B
| $7.38M | 0.08% |
82,974
-188,873
| -69% | -$17M |
|
269
Agilysys
AGYS
$3.21B
| $7.23M | 0.07% |
299,222
-6,870
| -2% | -$153K |
|
|
AMAG
270
DELISTED
AMAG Pharmaceuticals
AMAG
| $7.21M | 0.07% |
767,135
-28,476
| -4% | -$271K |
|
271
Mercury Insurance
MCY
$6B
| $7.19M | 0.07% |
173,813
-99,783
| -36% | -$4.29M |
|
272
Essent Group
ESNT
$6.28B
| $7.19M | 0.07% |
194,284
+12,410
| +7% | +$444K |
|
|
EVRI
273
DELISTED
Everi Holdings
EVRI
| $7.17M | 0.07% |
869,263
+347,961
| +67% | +$2.41M |
|
274
DXC Technology
DXC
$1.91B
| $7.17M | 0.07% |
401,507
+30,560
| +8% | +$558K |
|
275
Southwest Gas
SWX
$6.64B
| $7.15M | 0.07% |
113,349
-36,875
| -25% | -$2.46M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.